Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | -720 | 0 | 306 | 711 |
| Gross Profit | N/A | -720 | N/A | 306 | 711 |
| Operating Expenses | 3,275 | -13,115 | 4,518 | 13,739 | 13,695 |
| Operating Income | -3,275 | 12,395 | -4,518 | -13,433 | -12,984 |
| Other Income | 88 | 132 | 111 | 45 | 6 |
| Pre-tax Income | -3,187 | 12,527 | -4,407 | -13,388 | -12,978 |
| Net Income Continuous | -3,187 | 12,527 | -4,407 | -13,388 | -12,978 |
| Net Income Discontinuous | -3,767 | -19,743 | -6,089 | N/A | N/A |
| Net Income | $-6,954 | $-7,216 | $-10,496 | $-13,388 | $-12,978 |
| EPS Basic Total Ops | -3.20 | -3.29 | -4.83 | -6.16 | -6.00 |
| EPS Basic Continuous Ops | -1.46 | 5.77 | -2.03 | -6.16 | -5.98 |
| EPS Basic Discontinuous Ops | -1.73 | -9.09 | -2.80 | N/A | N/A |
| EPS Diluted Total Ops | -3.20 | -3.29 | -4.83 | -6.16 | -6.00 |
| EPS Diluted Continuous Ops | -1.46 | 5.77 | -2.03 | -6.16 | -5.98 |
| EPS Diluted Discontinuous Ops | -1.73 | -9.09 | -2.80 | N/A | N/A |
| EBITDA(a) | $-3,275 | $12,395 | $-4,518 | $-13,416 | $-12,936 |